Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stewart, K.
Right arrow Articles by Urschel, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Stewart, K.
Right arrow Articles by Urschel, J.

Chest, Vol 104, 98-100, Copyright © 1993 by American College of Chest Physicians

REVIEWS

Metastasis-induced acute pancreatitis as the initial manifestation of bronchogenic carcinoma

KC Stewart, WJ Dickout and JD Urschel
Thoracic Disease Unit, Misericordia Hospital, Edmonton, Canada.

Metastasis-induced pancreatitis (MIAP) is a very rare initial manifestation of lung cancer. A review of one institution's experience and the English language medical literature was conducted to define the incidence, natural history, and optimal treatment of this unusual clinical problem. One of 802 (0.12 percent) lung cancer patients presented with MIAP. Seven additional cases were found in the literature. Small-cell carcinoma was present in six of eight patients. Prognosis is poor. Four patients died within two weeks of hospital admission. In patients with small-cell carcinoma and mild pancreatitis, chemotherapy may favorably influence recovery from pancreatitis. Those with severe pancreatitis tolerate chemotherapy poorly and initial supportive management is advisable. Patients with small-cell histologic features who recover from pancreatitis should receive chemotherapy. Survival beyond six months is possible.


This article has been cited by other articles:


Home page
 Arch SurgHome page
K. Z'graggen, C. Fernandez-del Castillo, D. W. Rattner, H. Sigala, and A. L. Warshaw
Metastases to the Pancreas and Their Surgical Extirpation
Arch Surg, April 1, 1998; 133(4): 413 - 418.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American College of Chest Physicians.